Summit Panelist Spotlight: Dr. David Walk

by | Aug 23, 2016 | 1 comment

Walk, David-1David Walk, M.D. trained in neurology at the University of Chicago and has been at the University of Minnesota since 1999. His current clinical and research areas of focus are neuropathy, particularly small fiber neuropathy and CMT, and ALS.

He directs the University of Minnesota Health CMT multidisciplinary clinic. The University of Minnesota Health CMT clinic was recently named an HNF Center of Excellence. In addition, they are currently accepting patients for the Pharnext Phase 3 clinical trial of its lead pleodrug PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A).

Dr. Walk is especially interested in the value of the multidisciplinary team approach to helping people living with CMT and is excited about the emerging opportunities to advance care utilizing our expanding tools in neuromuscular genetics.

We’ve invited Dr. David Walk to join the panel discussion on “Genotype and Phenotype: Managing Symptoms, The Role of Researchers/Clinicians.”

Learn more on this topic

Related Blog Posts

Summit Speaker Spotlight: Dr. Robert Burgess

Dr. Burgess is on the scientific advisory board of the Hereditary Neuropathy Foundation, and also serves on the Cellular and Molecular Biology of Neurodegeneration grant review panel for the National Institutes of Health.

Summit Panelist Spotlight: Estela Lugo

A long-time member of the CMT community, HNF enlisted Estela to become a moderator for our CMT-Connect™ workshops. She has generously committed her time to help lead and teach other CMT patients in her community.

Join the conversation

Leave a Comment

1 Comment

  1. IGI

    Such an event should be available using teleconferencing
    You can still charge us


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news